Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy

Mitochondrial myopathies (MM) are a heterogeneous group of inherited conditions resulting from a primary defect in the mitochondrial respiratory chain with consecutively impaired cellular energy metabolism. Small sized studies using mainly electrocardiography (ECG) and echocardiography have revealed...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiovascular magnetic resonance Vol. 17; no. 1; p. 40
Main Authors Florian, Anca, Ludwig, Anna, Stubbe-Dräger, Bianca, Boentert, Matthias, Young, Peter, Waltenberger, Johannes, Rösch, Sabine, Sechtem, Udo, Yilmaz, Ali
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 22.05.2015
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Mitochondrial myopathies (MM) are a heterogeneous group of inherited conditions resulting from a primary defect in the mitochondrial respiratory chain with consecutively impaired cellular energy metabolism. Small sized studies using mainly electrocardiography (ECG) and echocardiography have revealed cardiac abnormalities ranging from conduction abnormalities and arrhythmias to hypertrophic or dilated cardiomyopathy in these patients. Recently, characteristic patterns of cardiac involvement were documented by cardiovascular magnetic resonance (CMR) in patients with chronic progressive external ophthalmoplegia (CPEO)/Kearns-Sayre syndrome (KSS) and with mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS). The present study aimed to characterize the prevalence and pattern of cardiac abnormalities and to test the additional diagnostic value of CMR in this patient population. The hypothesis that different neuromuscular MM syndromes present with different cardiac disease phenotypes was evaluated. Sixty-four MM patients (50 ± 15 years, 44% male) and 25 matched controls (52 ± 14 years, 36% male) prospectively underwent cardiac evaluations including CMR (comprising cine- and late-gadolinium-enhancement (LGE) imaging). Based on the neuromuscular phenotype and genotype, the patients were grouped: (a) CPEO/KSS (N = 33); (b) MELAS/-like (N = 11); c) myoclonic epilepsy with ragged-red fibers (MERRF) (N = 3) and d) other non-specific MM forms (N = 17). Among the 64 MM patients, 34 (53%) had at least one abnormal CMR finding: 18 (28%) demonstrated an impaired left ventricular ejection-fraction (LV-EF <60%), 14 (22%) had unexplained LV hypertrophy and 21 (33%) were LGE-positive. Compared to controls, MM patients showed significantly higher maximal wall thickness (10 ± 3 vs. 8 ± 2 mm, p = 0.005) and concentricity (LV mass to end-diastolic volume: 0.84 ± 0.27 vs. 0.67 ± 0.11, p < 0.0001) with frequent presence of non-ischemic LGE (30% vs. 0%, p = 0.001). CPEO/KSS showed a predominantly intramural pattern of LGE mostly confined to the basal LV inferolateral wall (8/10; 80%) in addition to a tendency toward concentric remodelling. MELAS/-like patients showed the highest frequency of cardiac disease (in 10/11 (91%)), a mostly concentric LV hypertrophy (6/9; 67%) with or without LV systolic dysfunction and a predominantly focal, patchy LGE equally distributed among LV segments (8/11; 73%). Patients with MERRF and non-specific MM had no particular findings. Pathological CMR findings indicating cardiac involvement were detected significantly more often than pathological ECG results or elevated cardiac serum biomarkers (34 (53%) vs. 18 (28%) vs. 21 (33%); p = 0.008). Cardiac involvement is a frequent finding in MM patients - and particularly present in KSS/CPEO as well as MELAS/-like patients. Despite a high variability in clinical presentation, CPEO/KSS patients typically show an intramural pattern of LGE in the basal inferolateral wall whereas MELAS patients are characterized by overt concentric hypertrophy and a rather unique, focally accentuated and diffusely distributed LGE.
AbstractList BACKGROUNDMitochondrial myopathies (MM) are a heterogeneous group of inherited conditions resulting from a primary defect in the mitochondrial respiratory chain with consecutively impaired cellular energy metabolism. Small sized studies using mainly electrocardiography (ECG) and echocardiography have revealed cardiac abnormalities ranging from conduction abnormalities and arrhythmias to hypertrophic or dilated cardiomyopathy in these patients. Recently, characteristic patterns of cardiac involvement were documented by cardiovascular magnetic resonance (CMR) in patients with chronic progressive external ophthalmoplegia (CPEO)/Kearns-Sayre syndrome (KSS) and with mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS). The present study aimed to characterize the prevalence and pattern of cardiac abnormalities and to test the additional diagnostic value of CMR in this patient population. The hypothesis that different neuromuscular MM syndromes present with different cardiac disease phenotypes was evaluated.METHODSSixty-four MM patients (50 ± 15 years, 44% male) and 25 matched controls (52 ± 14 years, 36% male) prospectively underwent cardiac evaluations including CMR (comprising cine- and late-gadolinium-enhancement (LGE) imaging). Based on the neuromuscular phenotype and genotype, the patients were grouped: (a) CPEO/KSS (N = 33); (b) MELAS/-like (N = 11); c) myoclonic epilepsy with ragged-red fibers (MERRF) (N = 3) and d) other non-specific MM forms (N = 17).RESULTSAmong the 64 MM patients, 34 (53%) had at least one abnormal CMR finding: 18 (28%) demonstrated an impaired left ventricular ejection-fraction (LV-EF <60%), 14 (22%) had unexplained LV hypertrophy and 21 (33%) were LGE-positive. Compared to controls, MM patients showed significantly higher maximal wall thickness (10 ± 3 vs. 8 ± 2 mm, p = 0.005) and concentricity (LV mass to end-diastolic volume: 0.84 ± 0.27 vs. 0.67 ± 0.11, p < 0.0001) with frequent presence of non-ischemic LGE (30% vs. 0%, p = 0.001). CPEO/KSS showed a predominantly intramural pattern of LGE mostly confined to the basal LV inferolateral wall (8/10; 80%) in addition to a tendency toward concentric remodelling. MELAS/-like patients showed the highest frequency of cardiac disease (in 10/11 (91%)), a mostly concentric LV hypertrophy (6/9; 67%) with or without LV systolic dysfunction and a predominantly focal, patchy LGE equally distributed among LV segments (8/11; 73%). Patients with MERRF and non-specific MM had no particular findings. Pathological CMR findings indicating cardiac involvement were detected significantly more often than pathological ECG results or elevated cardiac serum biomarkers (34 (53%) vs. 18 (28%) vs. 21 (33%); p = 0.008).CONCLUSIONCardiac involvement is a frequent finding in MM patients - and particularly present in KSS/CPEO as well as MELAS/-like patients. Despite a high variability in clinical presentation, CPEO/KSS patients typically show an intramural pattern of LGE in the basal inferolateral wall whereas MELAS patients are characterized by overt concentric hypertrophy and a rather unique, focally accentuated and diffusely distributed LGE.
Mitochondrial myopathies (MM) are a heterogeneous group of inherited conditions resulting from a primary defect in the mitochondrial respiratory chain with consecutively impaired cellular energy metabolism. Small sized studies using mainly electrocardiography (ECG) and echocardiography have revealed cardiac abnormalities ranging from conduction abnormalities and arrhythmias to hypertrophic or dilated cardiomyopathy in these patients. Recently, characteristic patterns of cardiac involvement were documented by cardiovascular magnetic resonance (CMR) in patients with chronic progressive external ophthalmoplegia (CPEO)/Kearns-Sayre syndrome (KSS) and with mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS). The present study aimed to characterize the prevalence and pattern of cardiac abnormalities and to test the additional diagnostic value of CMR in this patient population. The hypothesis that different neuromuscular MM syndromes present with different cardiac disease phenotypes was evaluated. Sixty-four MM patients (50 [+ or -] 15 years, 44 % male) and 25 matched controls (52 [+ or -] 14 years, 36 % male) prospectively underwent cardiac evaluations including CMR (comprising cine- and late-gadolinium-enhancement (LGE) imaging). Based on the neuromuscular phenotype and genotype, the patients were grouped: a) CPEO/KSS (N = 33); b) MELAS/-like (N = 11); c) myoclonic epilepsy with ragged-red fibers (MERRF) (N = 3) and d) other non-specific MM forms (N = 17). Among the 64 MM patients, 34 (53 %) had at least one abnormal CMR finding: 18 (28 %) demonstrated an impaired left ventricular ejection-fraction (LV-EF <60 %), 14 (22 %) had unexplained LV hypertrophy and 21 (33 %) were LGE-positive. Compared to controls, MM patients showed significantly higher maximal wall thickness (10 [+ or -] 3 vs. 8 [+ or -] 2 mm, p = 0.005) and concentricity (LV mass to end-diastolic volume: 0.84 [+ or -] 0.27 vs. 0.67 [+ or -] 0.11, p < 0.0001) with frequent presence of non-ischemic LGE (30 % vs. 0 %, p = 0.001). CPEO/KSS showed a predominantly intramural pattern of LGE mostly confined to the basal LV inferolateral wall (8/10; 80 %) in addition to a tendency toward concentric remodelling. MELAS/-like patients showed the highest frequency of cardiac disease (in 10/11 (91 %)), a mostly concentric LV hypertrophy (6/9; 67 %) with or without LV systolic dysfunction and a predominantly focal, patchy LGE equally distributed among LV segments (8/11; 73 %). Patients with MERRF and non-specific MM had no particular findings. Pathological CMR findings indicating cardiac involvement were detected significantly more often than pathological ECG results or elevated cardiac serum biomarkers (34 (53 %) vs. 18 (28 %) vs. 21 (33 %); p = 0.008). Cardiac involvement is a frequent finding in MM patients - and particularly present in KSS/CPEO as well as MELAS/-like patients. Despite a high variability in clinical presentation, CPEO/KSS patients typically show an intramural pattern of LGE in the basal inferolateral wall whereas MELAS patients are characterized by overt concentric hypertrophy and a rather unique, focally accentuated and diffusely distributed LGE.
Background Mitochondrial myopathies (MM) are a heterogeneous group of inherited conditions resulting from a primary defect in the mitochondrial respiratory chain with consecutively impaired cellular energy metabolism. Small sized studies using mainly electrocardiography (ECG) and echocardiography have revealed cardiac abnormalities ranging from conduction abnormalities and arrhythmias to hypertrophic or dilated cardiomyopathy in these patients. Recently, characteristic patterns of cardiac involvement were documented by cardiovascular magnetic resonance (CMR) in patients with chronic progressive external ophthalmoplegia (CPEO)/Kearns-Sayre syndrome (KSS) and with mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS). The present study aimed to characterize the prevalence and pattern of cardiac abnormalities and to test the additional diagnostic value of CMR in this patient population. The hypothesis that different neuromuscular MM syndromes present with different cardiac disease phenotypes was evaluated. Methods Sixty-four MM patients (50 [+ or -] 15 years, 44 % male) and 25 matched controls (52 [+ or -] 14 years, 36 % male) prospectively underwent cardiac evaluations including CMR (comprising cine- and late-gadolinium-enhancement (LGE) imaging). Based on the neuromuscular phenotype and genotype, the patients were grouped: a) CPEO/KSS (N = 33); b) MELAS/-like (N = 11); c) myoclonic epilepsy with ragged-red fibers (MERRF) (N = 3) and d) other non-specific MM forms (N = 17). Results Among the 64 MM patients, 34 (53 %) had at least one abnormal CMR finding: 18 (28 %) demonstrated an impaired left ventricular ejection-fraction (LV-EF <60 %), 14 (22 %) had unexplained LV hypertrophy and 21 (33 %) were LGE-positive. Compared to controls, MM patients showed significantly higher maximal wall thickness (10 [+ or -] 3 vs. 8 [+ or -] 2 mm, p = 0.005) and concentricity (LV mass to end-diastolic volume: 0.84 [+ or -] 0.27 vs. 0.67 [+ or -] 0.11, p < 0.0001) with frequent presence of non-ischemic LGE (30 % vs. 0 %, p = 0.001). CPEO/KSS showed a predominantly intramural pattern of LGE mostly confined to the basal LV inferolateral wall (8/10; 80 %) in addition to a tendency toward concentric remodelling. MELAS/-like patients showed the highest frequency of cardiac disease (in 10/11 (91 %)), a mostly concentric LV hypertrophy (6/9; 67 %) with or without LV systolic dysfunction and a predominantly focal, patchy LGE equally distributed among LV segments (8/11; 73 %). Patients with MERRF and non-specific MM had no particular findings. Pathological CMR findings indicating cardiac involvement were detected significantly more often than pathological ECG results or elevated cardiac serum biomarkers (34 (53 %) vs. 18 (28 %) vs. 21 (33 %); p = 0.008). Conclusion Cardiac involvement is a frequent finding in MM patients - and particularly present in KSS/CPEO as well as MELAS/-like patients. Despite a high variability in clinical presentation, CPEO/KSS patients typically show an intramural pattern of LGE in the basal inferolateral wall whereas MELAS patients are characterized by overt concentric hypertrophy and a rather unique, focally accentuated and diffusely distributed LGE. Keywords: Mitochondrial myopathy, Cardiomyopathy, Cardiovascular magnetic resonance, MELAS, CPEO
Mitochondrial myopathies (MM) are a heterogeneous group of inherited conditions resulting from a primary defect in the mitochondrial respiratory chain with consecutively impaired cellular energy metabolism. Small sized studies using mainly electrocardiography (ECG) and echocardiography have revealed cardiac abnormalities ranging from conduction abnormalities and arrhythmias to hypertrophic or dilated cardiomyopathy in these patients. Recently, characteristic patterns of cardiac involvement were documented by cardiovascular magnetic resonance (CMR) in patients with chronic progressive external ophthalmoplegia (CPEO)/Kearns-Sayre syndrome (KSS) and with mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS). The present study aimed to characterize the prevalence and pattern of cardiac abnormalities and to test the additional diagnostic value of CMR in this patient population. The hypothesis that different neuromuscular MM syndromes present with different cardiac disease phenotypes was evaluated. Sixty-four MM patients (50 ± 15 years, 44% male) and 25 matched controls (52 ± 14 years, 36% male) prospectively underwent cardiac evaluations including CMR (comprising cine- and late-gadolinium-enhancement (LGE) imaging). Based on the neuromuscular phenotype and genotype, the patients were grouped: (a) CPEO/KSS (N = 33); (b) MELAS/-like (N = 11); c) myoclonic epilepsy with ragged-red fibers (MERRF) (N = 3) and d) other non-specific MM forms (N = 17). Among the 64 MM patients, 34 (53%) had at least one abnormal CMR finding: 18 (28%) demonstrated an impaired left ventricular ejection-fraction (LV-EF <60%), 14 (22%) had unexplained LV hypertrophy and 21 (33%) were LGE-positive. Compared to controls, MM patients showed significantly higher maximal wall thickness (10 ± 3 vs. 8 ± 2 mm, p = 0.005) and concentricity (LV mass to end-diastolic volume: 0.84 ± 0.27 vs. 0.67 ± 0.11, p < 0.0001) with frequent presence of non-ischemic LGE (30% vs. 0%, p = 0.001). CPEO/KSS showed a predominantly intramural pattern of LGE mostly confined to the basal LV inferolateral wall (8/10; 80%) in addition to a tendency toward concentric remodelling. MELAS/-like patients showed the highest frequency of cardiac disease (in 10/11 (91%)), a mostly concentric LV hypertrophy (6/9; 67%) with or without LV systolic dysfunction and a predominantly focal, patchy LGE equally distributed among LV segments (8/11; 73%). Patients with MERRF and non-specific MM had no particular findings. Pathological CMR findings indicating cardiac involvement were detected significantly more often than pathological ECG results or elevated cardiac serum biomarkers (34 (53%) vs. 18 (28%) vs. 21 (33%); p = 0.008). Cardiac involvement is a frequent finding in MM patients - and particularly present in KSS/CPEO as well as MELAS/-like patients. Despite a high variability in clinical presentation, CPEO/KSS patients typically show an intramural pattern of LGE in the basal inferolateral wall whereas MELAS patients are characterized by overt concentric hypertrophy and a rather unique, focally accentuated and diffusely distributed LGE.
ArticleNumber 40
Audience Academic
Author Young, Peter
Florian, Anca
Sechtem, Udo
Yilmaz, Ali
Ludwig, Anna
Waltenberger, Johannes
Stubbe-Dräger, Bianca
Boentert, Matthias
Rösch, Sabine
Author_xml – sequence: 1
  givenname: Anca
  surname: Florian
  fullname: Florian, Anca
  email: ancarezeda.florian@ukmuenster.de
  organization: Department of Cardiology and Angiology, University Hospital Münster, Albert-Schweitzer-Campus 1, building A1, 48149, Münster, Germany. ancarezeda.florian@ukmuenster.de
– sequence: 2
  givenname: Anna
  surname: Ludwig
  fullname: Ludwig, Anna
  email: anna.ludwig@rbk.de
  organization: Division of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany. anna.ludwig@rbk.de
– sequence: 3
  givenname: Bianca
  surname: Stubbe-Dräger
  fullname: Stubbe-Dräger, Bianca
  email: bianca.draeger@ukmuenster.de
  organization: Department of Sleep Medicine and Neuromuscular Disorders, University Hospital Münster, Münster, Germany. bianca.draeger@ukmuenster.de
– sequence: 4
  givenname: Matthias
  surname: Boentert
  fullname: Boentert, Matthias
  email: matthias.boentert@ukmuenster.de
  organization: Department of Sleep Medicine and Neuromuscular Disorders, University Hospital Münster, Münster, Germany. matthias.boentert@ukmuenster.de
– sequence: 5
  givenname: Peter
  surname: Young
  fullname: Young, Peter
  email: peter.young@ukmuenster.de
  organization: Department of Sleep Medicine and Neuromuscular Disorders, University Hospital Münster, Münster, Germany. peter.young@ukmuenster.de
– sequence: 6
  givenname: Johannes
  surname: Waltenberger
  fullname: Waltenberger, Johannes
  email: johannes.waltenberger@ukmuenster.de
  organization: Department of Cardiology and Angiology, University Hospital Münster, Albert-Schweitzer-Campus 1, building A1, 48149, Münster, Germany. johannes.waltenberger@ukmuenster.de
– sequence: 7
  givenname: Sabine
  surname: Rösch
  fullname: Rösch, Sabine
  email: sabine.roesch@rbk.de
  organization: Division of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany. sabine.roesch@rbk.de
– sequence: 8
  givenname: Udo
  surname: Sechtem
  fullname: Sechtem, Udo
  email: udo.sechtem@rbk.de
  organization: Division of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany. udo.sechtem@rbk.de
– sequence: 9
  givenname: Ali
  surname: Yilmaz
  fullname: Yilmaz, Ali
  email: ali.yilmaz@ukmuenster.de
  organization: Department of Cardiology and Angiology, University Hospital Münster, Albert-Schweitzer-Campus 1, building A1, 48149, Münster, Germany. ali.yilmaz@ukmuenster.de
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26001801$$D View this record in MEDLINE/PubMed
BookMark eNptkluL3CAYhkPZ0j20P6A3RSiU3mSrJmpyU1iGnmChNy30Thz9nFgSTdVsN3-pv7IOsx12oIj4qc_7euC9rM588FBVLwm-JqTj7xKhPe9qTFjpLavvn1QXhDW0bmn_46zUuBc15604ry5T-okx6QUWz6pzykvdYXJR_dkMKiqdIbqUnUZaReOURvMAPuR1hoRUBGQgQ4EM2q4HJNyppJdRRTSpnYe9NEIKXnkNyHk0q-zA54R-uzwg46yFWOZIj847rcaTA7xBu-MsWDS5HPQQvImukNMaituwPq-eWjUmePEwXlXfP374tvlc33799GVzc1trxkWu-04xq5lhqmlEZ6mgBAjZciIs7YQ2xuKmZZqzZku6llNFdAOt1bClpPwPaa6q9wffedlOYHS5dlSjnKObVFxlUE6e7ng3yF24k23bY0G7YvD2wSCGXwukLCeXNIyj8hCWJAnvGlbAlhf09QHdqRGk8zYUR73H5Q1rCSOcClyo6_9QpRmYnC6ZsK6snwjePBIMoMY8pDAu2QWfTkFyAHUMKUWwx2cSLPcZk4eMyZIxuc-YvC-aV4__56j4F6rmLxxZ00Q
CitedBy_id crossref_primary_10_1002_ejhf_782
crossref_primary_10_1016_j_hfc_2021_07_003
crossref_primary_10_3233_JND_190415
crossref_primary_10_1007_s12170_023_00715_4
crossref_primary_10_2478_rjc_2023_0020
crossref_primary_10_1080_14656566_2019_1609941
crossref_primary_10_3390_diagnostics11020295
crossref_primary_10_3390_jcm7020016
crossref_primary_10_1186_s12872_020_01396_2
crossref_primary_10_1186_s12968_016_0311_9
crossref_primary_10_1016_j_parkreldis_2020_12_015
crossref_primary_10_1136_openhrt_2021_001819
crossref_primary_10_1016_j_ijcard_2015_10_054
crossref_primary_10_1007_s00059_018_4739_6
crossref_primary_10_1016_j_hrthm_2022_04_022
crossref_primary_10_3389_fcell_2020_624216
crossref_primary_10_4070_kcj_2016_46_2_117
crossref_primary_10_1148_ryct_230014
crossref_primary_10_1016_j_ymgme_2022_05_004
crossref_primary_10_1186_s12968_017_0423_x
crossref_primary_10_1016_j_jacc_2022_08_719
crossref_primary_10_1007_s11886_020_01311_3
crossref_primary_10_1155_2016_1490181
crossref_primary_10_1002_kjm2_12493
crossref_primary_10_1186_s12871_017_0385_4
crossref_primary_10_3348_kjr_2021_0815
crossref_primary_10_1055_a_2285_3481
crossref_primary_10_1093_qjmed_hcy290
crossref_primary_10_1186_s12968_016_0305_7
crossref_primary_10_1016_j_ahj_2020_04_006
crossref_primary_10_3390_jcm12103481
crossref_primary_10_1136_heartjnl_2015_308193
crossref_primary_10_1080_00015385_2024_2346873
crossref_primary_10_1093_ehjcr_ytad132
crossref_primary_10_1007_s11886_017_0875_5
crossref_primary_10_1097_MOP_0000000000000535
crossref_primary_10_3390_ijms22115742
crossref_primary_10_1007_s11910_021_01121_2
crossref_primary_10_1016_j_cca_2023_117691
crossref_primary_10_1161_CIRCGEN_121_003388
crossref_primary_10_1148_ryct_230144
crossref_primary_10_1161_CIRCULATIONAHA_117_031110
crossref_primary_10_1212_NXG_0000000000000339
crossref_primary_10_3390_jcdd11020040
crossref_primary_10_3348_kjr_2023_0531
crossref_primary_10_1093_brain_awx168
crossref_primary_10_1007_s10554_022_02774_x
Cites_doi 10.1542/peds.2004-0718
10.1136/heartjnl-2013-304657
10.1016/j.ijcard.2009.03.057
10.1161/CIRCULATIONAHA.107.691808
10.1093/eurjhf/hfs033
10.1212/WNL.0b013e3181d0ccf4
10.1016/j.jacc.2007.09.008
10.1212/WNL.53.4.855
10.1016/0002-8703(94)90272-0
10.1016/j.jacc.2010.05.007
10.1002/mus.23538
10.1161/CIRCRESAHA.111.246108
10.1093/ehjci/jes226
10.3345/kjp.2010.53.5.644
10.1161/CIRCIMAGING.109.883652
10.1186/1471-2261-2-12
10.1161/CIRCIMAGING.108.819938
10.1016/S0195-668X(02)00387-1
10.1161/CIRCHEARTFAILURE.111.963900
10.1536/ihj.53.383
10.1111/jnc.12217
10.1136/heartjnl-2013-305471
10.1007/s00392-011-0387-z
10.1093/eurheartj/ehs275
10.3109/07853890.2011.605389
10.1056/NEJMra022567
10.1016/j.ijcard.2006.07.121
10.1093/eurjhf/hfp186
10.1093/eurheartj/ehq443
10.1016/j.jacc.2010.05.010
10.1007/8904_2013_239
10.1161/01.CIR.103.2.226
10.1161/CIRCULATIONAHA.110.973305
10.1016/j.ijcard.2009.04.015
10.1093/eurheartj/ehu284
ContentType Journal Article
Copyright COPYRIGHT 2015 BioMed Central Ltd.
Florian et al.; licensee BioMed Central. 2015
Copyright_xml – notice: COPYRIGHT 2015 BioMed Central Ltd.
– notice: Florian et al.; licensee BioMed Central. 2015
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1186/s12968-015-0145-x
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-429X
EndPage 40
ExternalDocumentID A541516270
10_1186_s12968_015_0145_x
26001801
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GroupedDBID ---
-5E
-5G
-A0
-BR
.1-
.FO
0R~
0SF
29K
2WC
36B
3V.
4.4
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
AAFWJ
AAJSJ
AALRI
AAWTL
AAXUO
ABDBF
ABUWG
ACGEJ
ACGFO
ACGFS
ACIWK
ACPRK
ACRMQ
ADBBV
ADCVX
ADINQ
ADRAZ
ADUKV
ADVLN
ADXPE
AENEX
AFCTW
AFJKZ
AFKRA
AFRAH
AFRHN
AHBYD
AHMBA
AHSBF
AHYZX
AITUG
AJUYK
AJWEG
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMRAJ
AMTXH
AOIJS
ARAPS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
D-I
DIK
DU5
E3Z
EAD
EAP
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
EST
ESX
F5P
FDB
FRP
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ITC
KQ8
LK8
M1P
M41
M48
M7P
M~E
NPM
O5R
O5S
OK1
P2P
P62
P6G
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TDBHL
TFW
TR2
TUS
UKHRP
Z5R
ZCN
2VQ
AAYXX
AFPKN
AWYRJ
CAG
CITATION
COF
EBC
EBD
EPL
HZ~
IPNFZ
O9-
RIG
AFGXO
B0M
~8M
7X8
5PM
ID FETCH-LOGICAL-c567t-98a5fc5d5a3378f2721e11b617f287cddf0345c653b18462a1c3e4fceb2119713
IEDL.DBID RPM
ISSN 1097-6647
IngestDate Tue Sep 17 21:27:15 EDT 2024
Thu Jul 25 14:37:28 EDT 2024
Wed Aug 14 18:53:19 EDT 2024
Tue Aug 13 05:22:35 EDT 2024
Tue Aug 20 22:14:17 EDT 2024
Thu Sep 26 17:43:23 EDT 2024
Wed Oct 23 09:25:57 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c567t-98a5fc5d5a3378f2721e11b617f287cddf0345c653b18462a1c3e4fceb2119713
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490728/
PMID 26001801
PQID 1683572846
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4490728
proquest_miscellaneous_1683572846
gale_infotracmisc_A541516270
gale_infotracacademiconefile_A541516270
gale_healthsolutions_A541516270
crossref_primary_10_1186_s12968_015_0145_x
pubmed_primary_26001801
PublicationCentury 2000
PublicationDate 2015-05-22
PublicationDateYYYYMMDD 2015-05-22
PublicationDate_xml – month: 05
  year: 2015
  text: 2015-05-22
  day: 22
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of cardiovascular magnetic resonance
PublicationTitleAlternate J Cardiovasc Magn Reson
PublicationYear 2015
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References Raman (10.1186/s12968-015-0145-x_bib23) 2011; 32
Bates (10.1186/s12968-015-0145-x_bib17) 2013; 14
Bruder (10.1186/s12968-015-0145-x_bib33) 2010; 56
Baik (10.1186/s12968-015-0145-x_bib8) 2010; 53
Yilmaz (10.1186/s12968-015-0145-x_bib18) 2012; 101
Cheng (10.1186/s12968-015-0145-x_bib21) 2009; 2
DiMauro (10.1186/s12968-015-0145-x_bib25) 2003; 348
Cooper (10.1186/s12968-015-0145-x_bib36) 2007; 50
Limongelli (10.1186/s12968-015-0145-x_bib4) 2010; 12
Pfeffer (10.1186/s12968-015-0145-x_bib1) 2013; 45
Finsterer (10.1186/s12968-015-0145-x_bib30) 2007; 119
O'Hanlon (10.1186/s12968-015-0145-x_bib35) 2010; 56
Myerson (10.1186/s12968-015-0145-x_bib31) 2001; 103
Wahbi (10.1186/s12968-015-0145-x_bib12) 2010; 74
Holmgren (10.1186/s12968-015-0145-x_bib2) 2003; 24
Partington (10.1186/s12968-015-0145-x_bib16) 2011; 123
Dutta (10.1186/s12968-015-0145-x_bib22) 2012; 110
Stalder (10.1186/s12968-015-0145-x_bib27) 2012; 5
Bates (10.1186/s12968-015-0145-x_bib6) 2012; 33
McMurray (10.1186/s12968-015-0145-x_bib19) 2012; 14
Elliott (10.1186/s12968-015-0145-x_bib32) 2014; 35
Nakanishi (10.1186/s12968-015-0145-x_bib14) 2007; 116
Weidemann (10.1186/s12968-015-0145-x_bib24) 2013; 126
Sato (10.1186/s12968-015-0145-x_bib11) 1994; 128
Dominic (10.1186/s12968-015-0145-x_bib26) 2014; 100
Pfeffer (10.1186/s12968-015-0145-x_bib10) 2012; 46
Majamaa-Voltti (10.1186/s12968-015-0145-x_bib9) 2002; 2
Klopstock (10.1186/s12968-015-0145-x_bib3) 1999; 53
Hannah-Shmouni (10.1186/s12968-015-0145-x_bib29) 2014; 12
Palecek (10.1186/s12968-015-0145-x_bib15) 2012; 53
Khouri (10.1186/s12968-015-0145-x_bib20) 2010; 3
Jose (10.1186/s12968-015-0145-x_bib13) 2011; 149
Scaglia (10.1186/s12968-015-0145-x_bib5) 2004; 114
Meyers (10.1186/s12968-015-0145-x_bib7) 2013; 40
Ismail (10.1186/s12968-015-0145-x_bib34) 2014; 100
Finsterer (10.1186/s12968-015-0145-x_bib28) 2009; 137
References_xml – volume: 114
  start-page: 925
  year: 2004
  ident: 10.1186/s12968-015-0145-x_bib5
  article-title: Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease
  publication-title: Pediatrics
  doi: 10.1542/peds.2004-0718
  contributor:
    fullname: Scaglia
– volume: 100
  start-page: 611
  year: 2014
  ident: 10.1186/s12968-015-0145-x_bib26
  article-title: Mitochondrial cytopathies and cardiovascular disease
  publication-title: Heart
  doi: 10.1136/heartjnl-2013-304657
  contributor:
    fullname: Dominic
– volume: 149
  start-page: e24
  year: 2011
  ident: 10.1186/s12968-015-0145-x_bib13
  article-title: CMR gives clue to “ragged red fibers” in the heart in a patient with mitochondrial myopathy
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2009.03.057
  contributor:
    fullname: Jose
– volume: 116
  start-page: e25
  year: 2007
  ident: 10.1186/s12968-015-0145-x_bib14
  article-title: Images in cardiovascular medicine. Mitochondrial cardiomyopathy evaluated with cardiac magnetic resonance
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.691808
  contributor:
    fullname: Nakanishi
– volume: 14
  start-page: 803
  year: 2012
  ident: 10.1186/s12968-015-0145-x_bib19
  publication-title: Eur J Heart Fail
  doi: 10.1093/eurjhf/hfs033
  contributor:
    fullname: McMurray
– volume: 74
  start-page: 674
  year: 2010
  ident: 10.1186/s12968-015-0145-x_bib12
  article-title: Cardiac involvement is frequent in patients with the m.8344A > G mutation of mitochondrial DNA
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181d0ccf4
  contributor:
    fullname: Wahbi
– volume: 50
  start-page: 1914
  year: 2007
  ident: 10.1186/s12968-015-0145-x_bib36
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.09.008
  contributor:
    fullname: Cooper
– volume: 53
  start-page: 855
  year: 1999
  ident: 10.1186/s12968-015-0145-x_bib3
  article-title: Age and cause of death in mitochondrial diseases
  publication-title: Neurology
  doi: 10.1212/WNL.53.4.855
  contributor:
    fullname: Klopstock
– volume: 128
  start-page: 733
  year: 1994
  ident: 10.1186/s12968-015-0145-x_bib11
  article-title: Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes
  publication-title: Am Heart J
  doi: 10.1016/0002-8703(94)90272-0
  contributor:
    fullname: Sato
– volume: 56
  start-page: 875
  year: 2010
  ident: 10.1186/s12968-015-0145-x_bib33
  article-title: Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.05.007
  contributor:
    fullname: Bruder
– volume: 46
  start-page: 593
  year: 2012
  ident: 10.1186/s12968-015-0145-x_bib10
  article-title: Cardiac screening investigations in adult-onset progressive external ophthalmoplegia patients
  publication-title: Muscle Nerve
  doi: 10.1002/mus.23538
  contributor:
    fullname: Pfeffer
– volume: 110
  start-page: 1125
  year: 2012
  ident: 10.1186/s12968-015-0145-x_bib22
  article-title: Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.111.246108
  contributor:
    fullname: Dutta
– volume: 14
  start-page: 650
  year: 2013
  ident: 10.1186/s12968-015-0145-x_bib17
  article-title: Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers
  publication-title: Eur Heart J Cardiovasc Imaging
  doi: 10.1093/ehjci/jes226
  contributor:
    fullname: Bates
– volume: 53
  start-page: 644
  year: 2010
  ident: 10.1186/s12968-015-0145-x_bib8
  article-title: Electrocardiography as an early cardiac screening test in children with mitochondrial disease
  publication-title: Korean J Pediatr
  doi: 10.3345/kjp.2010.53.5.644
  contributor:
    fullname: Baik
– volume: 3
  start-page: 164
  year: 2010
  ident: 10.1186/s12968-015-0145-x_bib20
  article-title: A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study
  publication-title: Circ Cardiovasc Imaging
  doi: 10.1161/CIRCIMAGING.109.883652
  contributor:
    fullname: Khouri
– volume: 2
  start-page: 12
  year: 2002
  ident: 10.1186/s12968-015-0145-x_bib9
  article-title: Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A > G
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/1471-2261-2-12
  contributor:
    fullname: Majamaa-Voltti
– volume: 2
  start-page: 191
  year: 2009
  ident: 10.1186/s12968-015-0145-x_bib21
  article-title: Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis
  publication-title: Circ Cardiovasc Imaging
  doi: 10.1161/CIRCIMAGING.108.819938
  contributor:
    fullname: Cheng
– volume: 40
  start-page: 385
  year: 2013
  ident: 10.1186/s12968-015-0145-x_bib7
  article-title: Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management
  publication-title: Tex Heart Inst J
  contributor:
    fullname: Meyers
– volume: 24
  start-page: 280
  year: 2003
  ident: 10.1186/s12968-015-0145-x_bib2
  article-title: Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings
  publication-title: Eur Heart J
  doi: 10.1016/S0195-668X(02)00387-1
  contributor:
    fullname: Holmgren
– volume: 5
  start-page: e1
  year: 2012
  ident: 10.1186/s12968-015-0145-x_bib27
  article-title: Mitochondrial A3243G mutation with manifestation of acute dilated cardiomyopathy
  publication-title: Circ Heart Fail
  doi: 10.1161/CIRCHEARTFAILURE.111.963900
  contributor:
    fullname: Stalder
– volume: 53
  start-page: 383
  year: 2012
  ident: 10.1186/s12968-015-0145-x_bib15
  article-title: Hypertrophic cardiomyopathy due to the mitochondrial DNA mutation m.3303C > T diagnosed in an adult male
  publication-title: Int Heart J
  doi: 10.1536/ihj.53.383
  contributor:
    fullname: Palecek
– volume: 126
  start-page: 88
  issue: Suppl 1
  year: 2013
  ident: 10.1186/s12968-015-0145-x_bib24
  article-title: Cardiomyopathy of Friedreich ataxia
  publication-title: J Neurochem
  doi: 10.1111/jnc.12217
  contributor:
    fullname: Weidemann
– volume: 100
  start-page: 1851
  issue: 23
  year: 2014
  ident: 10.1186/s12968-015-0145-x_bib34
  article-title: Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy
  publication-title: Heart
  doi: 10.1136/heartjnl-2013-305471
  contributor:
    fullname: Ismail
– volume: 101
  start-page: 255
  year: 2012
  ident: 10.1186/s12968-015-0145-x_bib18
  article-title: Cardiovascular magnetic resonance imaging (CMR) reveals characteristic pattern of myocardial damage in patients with mitochondrial myopathy
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-011-0387-z
  contributor:
    fullname: Yilmaz
– volume: 33
  start-page: 3023
  year: 2012
  ident: 10.1186/s12968-015-0145-x_bib6
  article-title: Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehs275
  contributor:
    fullname: Bates
– volume: 45
  start-page: 4
  year: 2013
  ident: 10.1186/s12968-015-0145-x_bib1
  article-title: Diagnosis and treatment of mitochondrial myopathies
  publication-title: Ann Med
  doi: 10.3109/07853890.2011.605389
  contributor:
    fullname: Pfeffer
– volume: 348
  start-page: 2656
  year: 2003
  ident: 10.1186/s12968-015-0145-x_bib25
  article-title: Mitochondrial respiratory-chain diseases
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra022567
  contributor:
    fullname: DiMauro
– volume: 119
  start-page: 176
  issue: 2
  year: 2007
  ident: 10.1186/s12968-015-0145-x_bib30
  article-title: Cardiac involvement over 10 years in myotonic and Becker muscular dystrophy and mitochondrial disorder
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2006.07.121
  contributor:
    fullname: Finsterer
– volume: 12
  start-page: 114
  year: 2010
  ident: 10.1186/s12968-015-0145-x_bib4
  article-title: Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease
  publication-title: Eur J Heart Fail
  doi: 10.1093/eurjhf/hfp186
  contributor:
    fullname: Limongelli
– volume: 32
  start-page: 561
  year: 2011
  ident: 10.1186/s12968-015-0145-x_bib23
  article-title: Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehq443
  contributor:
    fullname: Raman
– volume: 56
  start-page: 867
  year: 2010
  ident: 10.1186/s12968-015-0145-x_bib35
  article-title: Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.05.010
  contributor:
    fullname: O'Hanlon
– volume: 12
  start-page: 17
  year: 2014
  ident: 10.1186/s12968-015-0145-x_bib29
  article-title: Increased prevalence of hypertension in young adults with high heteroplasmy levels of the MELAS m.3243A > G mutation
  publication-title: JIMD Rep
  doi: 10.1007/8904_2013_239
  contributor:
    fullname: Hannah-Shmouni
– volume: 103
  start-page: 226
  year: 2001
  ident: 10.1186/s12968-015-0145-x_bib31
  article-title: Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism: a randomized controlled trial with losartan
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.2.226
  contributor:
    fullname: Myerson
– volume: 123
  start-page: e227
  year: 2011
  ident: 10.1186/s12968-015-0145-x_bib16
  article-title: Cardiac magnetic resonance aids in the diagnosis of mitochondrial cardiomyopathy
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.973305
  contributor:
    fullname: Partington
– volume: 137
  start-page: e65
  year: 2009
  ident: 10.1186/s12968-015-0145-x_bib28
  article-title: MELAS in the heart
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2009.04.015
  contributor:
    fullname: Finsterer
– volume: 35
  start-page: 2733
  year: 2014
  ident: 10.1186/s12968-015-0145-x_bib32
  article-title: 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehu284
  contributor:
    fullname: Elliott
SSID ssj0019707
Score 2.3784623
Snippet Mitochondrial myopathies (MM) are a heterogeneous group of inherited conditions resulting from a primary defect in the mitochondrial respiratory chain with...
Background Mitochondrial myopathies (MM) are a heterogeneous group of inherited conditions resulting from a primary defect in the mitochondrial respiratory...
BACKGROUNDMitochondrial myopathies (MM) are a heterogeneous group of inherited conditions resulting from a primary defect in the mitochondrial respiratory...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 40
SubjectTerms Adult
Aged
Analysis
Arrhythmia
Cardiac patients
Cardiomyopathies - epidemiology
Cardiomyopathies - genetics
Cardiomyopathies - pathology
Cardiomyopathies - physiopathology
Care and treatment
Case-Control Studies
Diagnosis
Electrocardiogram
Electrocardiography
Epilepsy
Female
Genetic aspects
Genetic Predisposition to Disease
Germany - epidemiology
Humans
Hypertrophy, Left Ventricular - genetics
Hypertrophy, Left Ventricular - pathology
Hypertrophy, Left Ventricular - physiopathology
Kearns-Sayre Syndrome - genetics
Kearns-Sayre Syndrome - pathology
Magnetic Resonance Imaging
Male
MELAS Syndrome - genetics
MELAS Syndrome - pathology
MERRF Syndrome - genetics
MERRF Syndrome - pathology
Middle Aged
Mitochondrial Myopathies - epidemiology
Mitochondrial Myopathies - genetics
Mitochondrial Myopathies - pathology
Mitochondrial Myopathies - physiopathology
Myocardium - pathology
Ophthalmoplegia, Chronic Progressive External - genetics
Ophthalmoplegia, Chronic Progressive External - pathology
Phenotype
Physiological aspects
Predictive Value of Tests
Prevalence
Prospective Studies
Stroke Volume
Ventricular Function, Left
Ventricular Remodeling
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9VAEF5KBfFF6j226gqCIKyeTXY3yYNIKZYiHJ880Ldlb6kFT6Inp9Dzl_yVzmwudqUPPoYdNpf5ZmcmcyPkjROm9iqUzBtrmagsnINFyBlvuLGgkGsRU_6XX9XZSnw5l-d7ZBpvNX7A_lbXDudJrTY_3l__2n0Cgf8YBb5SH3rQWQpTsjANTUgGJuWdXBQCAb8Uf4MKdRmrpzHmypQS5RjkvHWLRE39e1jf0FZpJuUN1XR6QO6PNiU9HkDwgOyF9iG5uxyj5o_I75OkKzN1ERWOYnpXh_9ge2o2gfqAAYXgqd0NJHOaKl2bixarHSk45x226Aj0sqVjT9ae4s9cOo1a2dKp2jK5QevpxXzVNXQNRwl8_dajBND1rsPZyLvHZHX6-dvJGRtnNDAnVblldWVk46SXpijKqsnBoQycW7CLGvDFnPfNohDSKVlY8CVVbrgrgmgcOPQYwOTFE7Lfdm14RmijctzBLMCCE84CbrgM2K6Gl8qEkGfk3cQS_XNoxaGjC1MpPfBPA_808k9fZ-QVMk0P1aSzGOtjCRYLhzstMvI2UiC0gHfOjPUI8DDYEiuhPEooQQBdsvx6AobGJcxaa0N31WuuwL4twQBQGXk6AGV-chwMwME8yEiZQGgmwL7f6Up7-T32_xaiXsCuz__7BQ7JvTxCW7I8PyL7281VeAG21Na-jBLyB97_IAc
  priority: 102
  providerName: Scholars Portal
Title Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy
URI https://www.ncbi.nlm.nih.gov/pubmed/26001801
https://search.proquest.com/docview/1683572846
https://pubmed.ncbi.nlm.nih.gov/PMC4490728
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtB2MvY99z12UaDAYDN5Etyc5jFpqVQErZVsibkGS5C8xyaVJo_qX9lbuTP6j3uBeHoEssuN9Jd7q7nwj5ZLmeFtJlcaGNiXluYB1MXRKzkmkDG_KUh5L_1YU8v-LLtVgfENH1woSifWs2p_53deo3v0Jt5U1lx12d2PhyNeccQrokHx-SwyxNuxC9TR1Ms9AjjZnVWEqetalMlsvxFjY3ibVbWK_GRYwk1EjQzvL2TphuX_p3dX6wPQ1LJx_sRYtn5GnrRNJZM9nn5MD5F-Txqk2TvyR_5gMaZmoDDCzFeq4aD123VN86WjjMILiCmn0j0tel0kpfe2xvpBCN18jJ4ejG05aEdUvx9JZ2d6vsaNdeOXiBL-h1_60uaQVrB6y1vkDI02pf42XI-1fkanH2c34et5cyxFbIbBdPcy1KKwqh0zTLywQiSMeYAUeohODLFkU5SbmwUqQGgkeZaGZTx0sLETxmLFn6mhz52ru3hJYywX_QE3DZuDUAFCYc8tOwTGrnkoh86VSibhruDRVillyqRpUKVKlQleo-Ih9QaappH-3tVs0EuCgM3jSJyOcggZYLurO6bUCAySAH1kDyZCAJFmcHwx87YCgcwjI17-q7rWISHFpAJpcRedMApZ95B7SIZAMI9QJI9D0cAfwHwu8W78f__ct35EkSUC_iJDkhR7vbO_cenKmdGYEJrTN45otvI_JoNlv-WMLn17OLy--jcEABzxXPR8HI_gIpWShZ
link.rule.ids 230,315,733,786,790,870,891,2236,24346,27955,27956,31753,33407,33778,53825,53827
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXGkGAvfDMCgxkJCQkpbZ3YTvo4VUwF1omHDe3Nsh1nVJBkWlOJ8pP4ldzrxNWyN3is7DaJeu5X7rnHhLyzXE8L6bK40MbEPDfgB1OXxKxk2kBAnnJP-V-cyvk5_3whLnaICLMwnrRvzXJU_6xG9fK751ZeVXYceGLjr4sZ51DSJfn4DrkL9pqIUKT3zYNp5qeksbcaS8mzvpnJcjleQXiTyN5CxhoXMcpQo0Q7y_tTYUJkuu2fbwSoIXnyRjQ6fki-hefoSCg_RuvWjOzvWxKP__ygj8iDPj-lR93yY7Lj6ifk3qLvwD8lf2YDhWdqPcIsRapYg-9zV1RfO1o4bE64gppNt2VLeaWVvqxxcpJCod-g3Iejy5r2-q4rii-GaTi2paVhcnNwgbqgl9tPTUkrcEvgxusCrYlWmwbPWd48I-fHH89m87g_7yG2QmZtPM21KK0ohE7TLC8TKE4dYwZyrBLqOlsU5STlwkqRGqhLZaKZTR0vrTMoUwfV9nOyWze1e0FoKRP8BT2BbJBbAxhkwqH0Dcukdi6JyIfwX6urTtZD-XIol6rDiAKMKMSI-hWRQ0SD6iZTty5BHQnIfhhcaRKR934HOgUAhdX9bAPcDMprDXYeDHaCMdvB8tuAOIVLyICrXbNeKSYhVwYscBmR_Q6B2zsPCI5INsDmdgNqiA9XAHFeS7xH2Mv__uYhuT8_W5yok0-nX16RvcSbloiT5IDsttdr9xpytta88Rb6Fw4ZQ48
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LattAFB3aFEI3fTdRmzZTKBQKsjzSzEheBrcmfThk0UDoZpiXUtNIMrENdT-pX9l79cLKMksz15aEz33pnjlDyHvL9cRJn4ZOGxPyzEAcTHwcspxpAwl5wmvK__xMnl7wr5ficueor5q0b81iVF4Xo3Lxq-ZWLgsbdTyx6Hw-5RxaujiLli6P7pMH4LNx2jXq7QBhktY7pXG-GkrJ03agyTIZrSDFSWRwIWuNixClqFGmnWXtyTBddrodo3eS1JBAuZORZo_Jz-5ZGiLK79FmbUb27y2Zxzs97BPyqK1T6Ulj8pTc8-Uzsj9vJ_HPyb_pQOmZ2hppliJlrML3uiuqbzx1HocU3lGzbUx66ist9FWJOygpNPwVyn54uihpq_O6oviCmHbHt6xpt4NzcIHS0av-U5XTAsIThPPSoVfRYlvhecvbF-Ri9vnH9DRsz30IrZDpOpxkWuRWOKGTJM3yGJpUz5iBWiuH_s46l48TLqwUiYH-VMaa2cTz3HqDcnXQdb8ke2VV-kNCcxnjL-gxVIXcGsAiEx4lcFgqtfdxQD52_7daNvIeqm6LMqkanCjAiUKcqD8BOUZEqGaHah8a1ImAKojBlcYB-VBbYHAAYFjd7nGAm0GZrYHl0cASnNoOlt91qFO4hEy40leblWISambAA5cBOWhQ2N95h-KApAN89gaoJT5cAdTVmuItyl7d-ZvHZP_800x9_3L27TV5GNfeJcI4PiJ765uNfwOl29q8rZ30PwFnRg8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characteristic+cardiac+phenotypes+are+detected+by+cardiovascular+magnetic+resonance+in+patients+with+different+clinical+phenotypes+and+genotypes+of+mitochondrial+myopathy&rft.jtitle=Journal+of+cardiovascular+magnetic+resonance&rft.au=Florian%2C+Anca&rft.au=Ludwig%2C+Anna&rft.au=Stubbe-Dr%C3%A4ger%2C+Bianca&rft.au=Boentert%2C+Matthias&rft.date=2015-05-22&rft.pub=BioMed+Central+Ltd&rft.issn=1097-6647&rft.volume=17&rft_id=info:doi/10.1186%2Fs12968-015-0145-x&rft.externalDocID=A541516270
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1097-6647&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1097-6647&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1097-6647&client=summon